Global pharmaceutical company GlaxoSmithKline (GSK) has signed a 15 1/2-year lease to occupy a new $81 million building at Philadelphia's Navy Yard Corporate Center to be developed by Liberty Property Trust (NYSE:LRY) and Synterra Partners.
Global pharmaceutical company GlaxoSmithKline (GSK) has signed a 15 1/2-year lease to occupy a new $81 million building at Philadelphia's Navy Yard Corporate Center to be developed by Liberty Property Trust (NYSE:LRY) and Synterra Partners.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In